Publications

  1. Alimirzaie S, Bagherzadeh M, Akbari MR. Liquid Biopsy in Breast Cancer: A Comprehensive Review. Clin Genet. 2019 Jan 22. [Epub ahead of print]

  2. Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Rusak B, Stempa K, Kashyap A, Szwiec M, Jakubowska A, Dębniak T, Gronwald J, Jarkiewicz-Tretyn J, Stawicka M, Narod SA, Lubiński J, Akbari MR, the Polish Hereditary Breast Cancer Consortium. The Spectrum of Mutations Predisposing to Familial Breast Cancer in Poland. American Journal of Human Genetics Journal. January 2019. [Under Review]

  3. Rusak B, Kluźniak W, Wokołorczyk D, Stempa K, Kashyap A, Gronwald J, Huzarski T, Dębniak T, Jakubowska A, Masojć B, Akbari MR, Narod SA, Lubiński J, Cybulski C; Polish Hereditary Prostate Cancer Consortium. Inherited NBN Mutations and Prostate Cancer Risk and Survival. Cancer Res Treat. 2018 Dec 13. [Epub ahead of print]

  4. Donenberg T, George S, Ali J, Bravo G, Hernandez K, Sookar N, Ashing KT, Narod SA, Akbari MR, Hurley J. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families. Breast Cancer Res Treat. 2018 Dec 4.[Epub ahead of print]

  5.  Lee DD, Leão R, Komosa M, Gallo M, Zhang CH, Lipman T, Remke M, Heidari A, Nunes NM, Apolónio JD, De Mello RA, Dias J, Huntsman D, Hermanns T, Wild PJ, Vanner R, Zadeh G, Karamchandani J, Das S, Taylor MD, Hawkins CE, Wasserman JD, Figueiredo A, Hamilton RJ, Minden MD, Wani K, Diplas B, Yan H, Aldape K, Akbari MR, Danesh A, Pugh TJ, Dirks PB, Castelo-Branco P, Tabori U. DNA hypermethylation within TERT promoter upregulates TERT expression in cancer. J Clin Invest. 2018 Oct 25. [Epub ahead of print]

  6. Ahmed H, Lerner-Ellis J, Cybulski C, Metcalfe K, Lubiński J, Narod SA, Akbari. Reply to 'Mutations in RECQL are not associated with breast cancer risk in an Australian population'. Nat Genet. 2018 Oct;50(10):1348-1349.

  7. Metcalfe K, Akbari MR, Narod SA. Genetic testing for young women with breast cancer. Lancet Oncol. 2018 Apr;19(4):e182.

  8. Grant RC, Holter S, Borgida A, Dhani NC, Hedley DW, Knox JJ, Akbari MR, Zogopoulos G, Gallinger S. Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer. J Genet Couns. 2018 Aug;27(4):988-995.

  9. Narod S, Akbari MR. Population-Based Genetic Testing for BRCA1 and BRCA2. J Clin Oncol. 2018 Jan 2: 36(5):517

  10. Narod SA, Butler R, Bobrowski D, Akbari MR, Curling D, Lunn J, Ho C, Panahi S, Llacuachaqui M, Donenberg T, Hurley J. Short report: Follow-up of Bahamian women with a BRCA1 or BRCA2 mutation. Mol Genet Genomic Med. 2017 Dec 20. [Epub ahead of print]

  11. Ahmed H, Akbari H, Emami A, Akbari MR. Genetic Overview of Syndactyly and Polydactyly. Plastic and Reconstructive Surgery-Global Open. Plast Reconstr Surg Glob Open. 2017 Nov 2;5(11):e1549.

  12. Akbari MR, Gojska N, Narod SA. Coming of Age in Canada: A Study of Population-Based Genetic Testing for Breast and Ovarian Cancer. Curr Oncol. 2017 Oct;24(5):282-283.

  13. Alimirzaie S, Mohammadkhani A , Masoudi S, Sellars E, Boffetta P, Malekzadeh R, Akbari MR, Pourshams A. Screening of young age at onset pancreatic cancer patients for mutations in known and novel cancer susceptibility genes. Arch Iran Med. 2018 Jun1;21(6):228-233.

  14. Smith AL,  Wong C, Cuggia A, Borgida A, Holter S, Hall A, Connor AA, Bascuñana C, Poulin V, Jolivet J, Vafidis P, Le P, Martel G, Lemay F, Beaudoin A, Chaudhury P, Barkun J, Metrakos P,  Marcus V, Omeroglu A, Chong G, Akbari MR, Foulkes WD, Gallinger S, Zogopoulos G. Reflex testing for BRCA1, BRCA2, PALB2 and ATM germline mutations in pancreatic cancer: a mutation prevalence and clinical outcome study from two Canadian cancer centers. JCO Precision Oncology [Accepted]

  15. Lebo MS, Zakoor KR, Chun K, Speevak MD, Waye JS, McCready E, Parboosingh JS, Lamont RE, Feilotter H, Bosdet I, Tucker T, Young S, Karsan A, Charames GS, Agatep R, Spriggs EL, Chisholm C, Vasli N, Daoud H, Jarinova O, Tomaszewski R, Hume S, Taylor S, Akbari MR, Lerner-Ellis J; Canadian Open Genetics Repository Working Group. Data sharing as a national quality improvement program: reporting on BRCA1 and BRCA2 variant-interpretation comparisons through the Canadian Open Genetics Repository (COGR). Genet Med. 2017 Jul 20. [Epub ahead of print] 

  16. Wallis CJD, Akbari MR, Narod SA, Nam RK. RE: Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.JNCI [Ahead of Print]

  17. Narod SA, Akbari MR. Mutation Frequencies in Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017 Nov 1;3(11):1586-1587.

  18. Rivera B, Di Iorio M, Frankum J, Nadaf J, Fahiminiya S, Arcand SL, Burk DL, Grapton D, Tomiak E, Hastings V, Hamel N, Wagener R, Aleynikova O, Giroux S, Hamdan FF, Dionne-Laporte A, Zogopoulos G, Rousseau F, Berghuis AM, Provencher D, Rouleau GA, Michaud JL, Mes-Masson AM, Majewski J, Bens S, Siebert R, Narod SA, Akbari MR, Lord CJ, Tonin PN, Orthwein A, Foulkes WD. Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma. Cancer Res. 2017 Aug 15;77(16):4517-4529. 

  19. Lerner-Ellis J, Donenberg T, Ahmed H, George S, Wharfe G, Chin S, Lowe D, Royer R, Zhang S, Narod S, Hurley J, Akbari MR. A high frequency of PALB2 mutations in Jamaican patients with breast cancer. Breast Cancer Res Treat. 2017 Apr;162(3):591-596.

  20. Fattahi Z, Kalhor Z, Fadaee M, Vazehan R, Parsimehr E, Abolhassani A, Beheshtian M, Zamani G, Nafissi S, Nilipour Y, Akbari MR, Kahrizi K, Kariminejad A, Najmabadi H. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. 2017 Mar;91(3):386-402.

  21. Akbari MR, Zhang S, Cragun D, Lee JH, Coppola D, McLaughlin J, Risch HA, Rosen B, Shaw P, Sellers TA, Schildkraut J, Narod SA, Pal T. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens. Fam Cancer. 2017 Jul;16(3):351-355.

  22. Nagrani R, Mhatre S, Rajaraman P, Chatterjee N, Akbari MR, Boffetta P, Brennan P, Badwe R, Gupta S, Dikshit R. Association of Genome-Wide Association Study (GWAS) Identified SNPs and Risk of Breast Cancer in an Indian Population. Sci Rep. 2017 Jan 18;7:40963.

  23. Moran O, Nikitina D, Royer R, Poll A, Metcalfe K, Narod SA, Akbari MR, Kotsopoulos J. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel. Breast Cancer Res Treat. 2017 Jan;161(1):135-142.

  24. Kotsopoulos J, Sopik V, Rosen B, Fan I, McLaughlin JR, Risch H, Sun P, Narod SA, Akbari MR. Frequency of germline PALB2 mutations among women with epithelial ovarian cancer. Fam Cancer. 2017 Jan;16(1):29-34. PubMed PMID: 27631815.

  25. Narod SA, Ahmed H, Akbari MR. Do acronyms belong in the medical literature?: A Countercurrents Series. Curr Oncol. 2016 Oct;23(5):295-296.

  26. Chehade R, Pettapiece-Phillips R, Salmena L, Kotlyar M, Jurisica I, Narod SA, Akbari MR, Kotsopoulos J. Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific. Breast Cancer Res. 2016 Aug 17;18(1):87.

  27. Donenberg T, Ahmed H, Royer R, Zhang S, Narod SA, George S, Akbari MR, Ali J, Hurley J. A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago. Breast Cancer Res Treat. 2016 Aug;159(1):131-8.

  28. Kim SJ, Zuchniak A, Sohn KJ, Lubinski J, Demsky R, Eisen A, Akbari MR, Kim YI, Narod SA, Kotsopoulos J. Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study. Am J Clin Nutr. 2016 Sep;104(3):671-7.

  29. Kwong A, Shin VY, Cheuk IW, Chen J, Au CH, Ho DN, Chan TL, Ma ES, Akbari MR, Narod SA. Germline RECQL mutations in high risk Chinese breast cancer patients. Breast Cancer Res Treat. 2016 June;157(2):211-5.

  30. Fattahi Z, Kalhor Z, Fadaee M, Vazehan R, Parsimehr E, Abolhassani A, Beheshtian M, Zamani G, Nafissi S, Nilipour Y, Akbari MR, Kahrizi K, Kariminejad A, Najmabadi H. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. 2017 Mar;91(3):386-402.

  31. Esmail Nia G, Fadaee M, Royer R, Najmabadi H, Akbari MR. Profiling Fanconi Anemia Gene Mutations among Iranian Patients. Arch Iran Med. 2016 Apr;19(4):236-40.

  32. Fadaee M, Kariminejad A, Fattahi Z, Nafissi S, Godarzi HR, Beheshtian M, Vazehan R, Akbari MR, Kahrizi K, Najmabadi H. Report of limb girdle muscular dystrophy type 2a in 6 Iranian patients, one with a novel deletion in CAPN3 gene. Neuromuscul Disord. 2016 Apr-May;26(4-5):277-82.

  33. Faraji Zonooz M, Sabbagh-Kermani F, Fattahi Z, Fadaee M, Akbari MR, Amiri R, Vahidnezhad H, Uitto J, Najmabadi H, Kariminejad A. Whole Genome Linkage Analysis Followed by Whole Exome Sequencing Identifies Nicastrin (NCSTN) as a Causative Gene in a Multiplex Family with γ-Secretase Spectrum of Autoinflammatory Skin Phenotypes. J Invest Dermatol. 2016 Jun;136(6):1283-6.

  34. Babanejad M, Moein H, Akbari MR, Badiei A, Yaseri M, Soheilian M, Najmabadi H. Investigating the CFH Gene Polymorphisms as a Risk Factor for Age-related Macular Degeneration in an Iranian Population. Ophthalmic Genet. 2016 June;37(2):144-9.

  35. Trottier M, Lunn J, Butler R, Curling D, Turnquest T, Francis W, Halliday D, Royer R, Zhang S, Li S, Thompson I, Donenberg T, Hurley J, Akbari MR, Narod SA. Prevalence of Founder Mutations in the BRCA1 and BRCA2 genes among Unaffected Women from the Bahamas. Clin Genet. 2016 Mar;89(3):328-31.

  36. Segev Y, Zhang S, Akbari MR, Sun P, Sellers TA, McLaughlin J, Risch HA, Rosen B, Shaw P, Schildkraut J, Narod SA, Pal T. Survival in women with ovarian cancer with and without microsatellite instability. Eur J Gynaecol Oncol. 2015;36(6):681-4.

  37. Pal T, Bonner D, Cragun D, Monteiro AN, Phelan C, Servais L, Kim J, Narod SA, Akbari MR, Vadaparampil ST. A high frequency of BRCA mutations in young black women with breast cancer residing in Florida. Cancer. 2015 Dec 1;121(23):4173-80.

  38. Pettapiece-Phillips R, Kotlyar M, Chehade R, Salmena L, Narod SA, Akbari MR, Jurisica I, Kotsopoulos J.Uninterrupted sedentary behavior downregulates BRCA1 gene expression. Cancer Prev Res (Phila). 2015 Nov 2. pii: canprevres.0291.

  39. Beheshtian M, Saee Rad S, Babanejad M, Mohseni M, Hashemi H, Eshghabadi A, Hajizadeh F, Akbari MR, Kahrizi K, Riazi Esfahani M, Najmabadi H. Impact of Whole Exome Sequencing among Iranian Patients with Autosomal Recessive Retinitis Pigmentosa. Arch Iran Med. 2015 Nov;18(11):776-85. 

  40. Akbari MR, Cybulski C. RECQL: a DNA helicase in breast cancer. Oncotarget. 2015 Sep 29;6(29):26558-9.

  41. Cybulski C, Carrot-Zhang J, Kluzniak W, Rivera B, Kashyap A, Wokolorczyk D, Giroux S, Nadaf J, Hamel N, Zhang S, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Rudnicka H, Lener M, Masojc B, Tonin PN, Rousseau F, Gorski B, Debniak T, Majewski J, Lubinski J, Foulkes WD, Narod SA, Akbari MR. Germline RECQL mutations are associated with breast cancer susceptibility. Nat Genet. 2015 Jun;47(6):643-6.

  42. Giannakeas V, Sopik V, Shestopaloff K, Iqbal J, Rosen B, Akbari MR, Narod SA. A model for estimating ovarian cancer risk: Application for preventive oophorectomy. Gynecol Oncol. 2015 Sep 2. pii: S0090-8258(15)30112-8.

  43. Mehrjoo Z, Akbari MR, Abedini SS, Vaziri S, Kahrizi K, Najmabadi H. Carrier Testing in Known Autosomal Recessive Intellectual Disability Genes in an Iranian Healthy Individual Using Exome Sequencing. Arch Iran Med. 2015 Oct;18(10):643-69.

  44. Lerner-Ellis J, Wang M, White S, Lebo MS; Canadian Open Genetics Repository Group. Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations. J Med Genet. 2015 Jul;52(7):438-45. 

  45. Arcand SL, Akbari MR, Mes-Masson AM, Provencher D, Foulkes WD, Narod SA, Tonin PN. Germline TP53 mutational spectrum in French Canadians with breast cancer. BMC Med Genet. 2015 Apr 12;16(1):24.

  46. Akhtarkhavari T, Joghataei MT, Fattahi Z, Akbari MR, Larti F, Najmabadi H, Kahrizi K. Genetic Investigation of an Iranian Supercentenarian by Whole Exome Sequencing. Arch Iran Med. 2015 Oct;18(10):688-97.

  47. Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Dębniak T, Górski B, Sopik V, Akbari MR, Sun P, Gronwald J, Narod SA, Lubiński J; Polish Hereditary Breast Cancer Consortium. Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol. 2015 Jun;16(6):638-44.

  48. Holter S, Borgida A, Dodd A, Grant R, Semotiuk K, Hedley D, Dhani N, Narod S, Akbari MR, Moore M, Gallinger S. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma. J Clin Oncol. 2015 Oct 1;33(28):3124-9.

  49. Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat. 2015 May;151(1):169-76.

  50. Snyder C, Metcalfe K, Sopik V, Royer R, Zhang S, Narod SA, Akbari MR, Lynch HT. Prevalence of PALB2 mutations in the Creighton University Breast Cancer Family Registry. Breast Cancer Res Treat. 2015 Apr;150(3):637-41.

  51. Villarreal-Garza C, Weitzel JN, Llacuachaqui M, Sifuentes E, Magallanes-Hoyos MC, Gallardo L, Alvarez-Gomez RM, Herzog J, Castillo D, Royer R, Akbari MR, Lara-Medina F, Herrera LA, Mohar A, Narod SA. The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer. Breast Cancer Res Treat. 2015 Apr;150(2):389-94.

  52. Mohamadkhani A, Akbari MR, Ghanbari R, Naderi E, Rezanejad-Asl P, Pourshams A. Direct Sequencing of Cyclooxygenase-2 (COX-2) Revealed an Intronic Variant rs201231411 in Iranian Patients with Pancreatic Cancer. Middle East J Dig Dis. 2015 Jan;7(1):14-8.

  53. Fattahi Z, Kahrizi K, Nafissi S, Fadaee M, Abedini SS, Kariminejad A, Akbari MR, Najmabadi H. Report of a patient with limb-girdle muscular dystrophy, ptosis and ophthalmoparesis caused by plectinopathy. Arch Iran Med. 2015 Jan;18(1):60-4.

  54. Sopik V, Akbari MR, Narod SA. Genetic testing for RAD51C mutations: in the clinic and community. Clin Genet. 2015 Oct;88(4):303-12.

  55. Torres-Mejia G, Royer R, Llacuachaqui M, Akbari MR, Giuliano AR, Martínez-Matsushita L, Angeles-Llerenas A, Ortega-Olvera C, Ziv E, Lazcano-Ponce E, Phelan CM, Narod SA. Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):498-505.

  56. Schütz E, Akbari MR, Beck J, Urnovitz H, Zhang W, Mitchell WM, Nam RK, Narod SA. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clin Chem. 2015 Jan;61(1):239-48.

  57. Cybulski C, Lubiński J, Wokołorczyk D, Kuźniak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Górski B, Dębniak T, Narod SA, Akbari MR. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland. Clin Genet. 2015 Oct;88(4):366-70.

  58. Akbari MR, Wallis CJD, Toi A, Trachtenberg J, Sun P, Narod SA, Nam RK. The Impact of a BRCA2 Mutation on Mortality from Screen-Detected Prostate Cancer. Br J Cancer. 2014 Sep 9;111(6):1238-40.

  59. Kotsopoulos J, Zhang S, Akbari MR, Salmena L, Llacuachaqui M, Zeligs M, Sun P, Narod SA. BRCA1 mRNA Levels Following a 4-6 Week Intervention with Oral 3,3'-Diindolylmethane. Br J Cancer. 2014 Sep 23;111(7):1269-74.

  60. Trottier M, Lunn J, Butler R, Curling D, Turnquest T, Royer R, Akbari MR, Donenberg T, Hurley J, Narod SA. Strategies for Recruitment of Relatives of BRCA Mutation Carriers to a Genetic Testing Program in the Bahamas. 2015 Aug;88(2):182-6.

  61. Kotsopoulos J, Metcalfe KA, Alston J, Nikitina D, Ginsburg OM, Eisen A, Demsky R, Akbari M, Zbuk K, Narod SA. Prospective Study of High-Risk, BRCA1/2-Mutation Negative Women: the 'Negative Study'. BMC Cancer. 2014 Mar 25;14:221.

  62. Fattahi Z, Rostami P, Najmabadi A, Mohseni M, Kahrizi K, Akbari MR, Kariminejad A, Najmabadi H. Mutation profile of BBS genes in Iranian patients with Bardet-Biedl syndrome: genetic characterization and report of nine novel mutations in five BBS genes. J Hum Genet 2014;59(7):368-75.

  63. Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari MR, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T. Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer. Genet Test Mol Biomarkers. 2014 Apr;18(4):229-35.

  64. Malekzadeh MM, Radmard AR, Nouroozi A, Akbari MR, Amini M, Navabakhsh B, Caleffi A, Pietrangelo A, Malekzadeh R. Juvenile Hemochromatosis, Genetic Study and Long-term Follow up after Therapy. Middle East J Dig Dis. 2014 Apr;6(2):87-92.

  65. McMullin RP, Wittner BS, Yang C, Denton-Schneider BR, Hicks D, Singavarapu R, Moulis S, Lee J, Akbari MR, Narod SA, Aldape KD, Steeg PS, Ramaswamy S, Sgroi DC. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Res. 2014;16(2):R25.

  66. Szwiec M, Jakubowska A, Górski B, Huzarski T, Tomiczek-Szwiec J, Gronwald J, Dębniak T, Byrski T, Kluźniak W, Wokołorczyk D, Birkenfeld B, Akbari MR, Narod SA, Lubiński J, Cybulski C. Recurrent mutations of BRCA1 and BRCA2 in Poland: an update. Clin Genet. 2015 Mar;87(3):288-92.

  67. Akbari MR, Lepage P, Rosen B, McLaughlin J, Risch H, Minden M, Narod SA. PPM1D mutations in circulating white blood cells and the risk for ovarian cancer. J Natl Cancer Inst. 2014 ;106(1):djt323.

  68. Pal T, Bonner D, Cragun D, Johnson S, Akbari M, Servais L, Narod S, Vadaparampil S. BRCA sequencing and large rearrangement testing in young Black women with breast cancer. J Community Genet. 2014;5(2):157-65.

  69. Kashyap A, Kluźniak W, Wokołorczyk D, Gołąb A, Sikorski A, Słojewski M, Gliniewicz B, Świtała J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała P, Piotrowski K,  Jakubowska A, Gronwald J, Huzarski T1, Byrski T, Dębniak T, Górski B, Masojć B, Wetering T, Menkiszak  J, Akbari MR, Lubiński J, Narod SA, Cybulski C and the Polish Hereditary Prostate Cancer Consortium. The Presence of Prostate Cancer at Biopsy is Predicted by a Number of Genetic Variants. Int J Can. 2014;134(5):1139-46.

  70. Akbari MR, Donenberg T, Lunn J, Curling D, Turnquest T, Krill-Jackson E, Zhang S, Narod S, Hurley J. The spectrum of BRCA1 and BRCA2 mutations in breast cancer patients in the Bahamas. Clin Genet. 2014; 85(1):64-7.

  71. Moghtadaei M, Hashemi Golpayegani MR, Almasganj F, Etemadi A, Akbari MR, Malekzadeh R. Predicting the risk of squamous dysplasia and esophageal squamous cell carcinoma using minimum classification error method. Computers in Biology and Medicine 2014; 45:51-7.

  72. Antczak A, Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J,Huzarski T, Byrski T, Dębniak T, Masojć B, Górski B, Gromowski T, Nagorna A,Gołąb A, Sikorski A, Słojewski M, Gliniewicz B, Borkowski T, Borkowski A,Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Domagała P, Stawicka M, Milecki P, Akbari MR, Narod SA, Lubiński J, Cybulski C; Polish Hereditary Prostate Cancer Consortium; Other members of the Polish Hereditary Prostate Cancer Consortium,Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P,Skrzypczyk M, Dobruch J, Domagała W, Chosia M, van de Wetering T,Serrano-Fernández P, Puszyński M, Soczawa M, Switała J, Archimowicz S, Kordowski M, Zyczkowski M, Borówka A, Bagińska J, Krajka K, Szwiec M, Haus O, Janiszewska H, Stembalska A, Sąsiadek MM. A common nonsense mutation of the BLM gene and prostate cancer risk and survival. Gene. 2013 Dec 15;532(2):173-6.

  73. Akbari MR, Anderson LN, Buchanan DD, Clendenning M, Jenkins MA, Win AK, Hopper JL, Giles GG, Nam R, Narod S, Gallinger S, Cleary SP. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiol. 2013 Aug;37(4):424-7.

  74. Gupta IR, Baldwin C, Auguste D, Ha KC, El Andalousi J, Fahiminiya S, Bitzan M, Bernard C, Akbari MR, Narod SA, Rosenblatt DS, Majewski J, Takano T. ARHGDIA: a novel gene implicated in nephrotic syndrome. J Med Genet. 2013 May;50(5):330-8.

  75. Akbari MR, Kluźniak W, Rodin R, Li S, Wokołorczyk D, Royer R, Kashyap A,Menkiszak J, Lubinski J, Narod SA, Cybulski C. The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer. Breast Cancer Res Treat 2012;136(3):907-9.

  76. Kluźniak W, Wokołorczyk D, Kashyap A, Jakubowska A, Gronwald J, Huzarski T,Byrski T, Dębniak T, Gołąb A, Gliniewicz B, Sikorski A, Switała J, Borkowski T,Borkowski A, Antczak A, Wojnar L, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała P, Akbari MR, Lubiński J, Narod SA, Cybulski C; the Polish Hereditary Prostate Cancer Consortium. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland. Prostate 2013: 73(5):542-8.

  77. Akbari MR, Pal T, Sun P, Lee JH, Fulp J, Thompson Z, Coppola D, Nicosia S, Sellers TA, McLaughlin J, Schildkraut J, Narod SA. Frequency of Mutations in Mismatch Repair Genes in a Population-based Sample of Women with Ovarian Cancer. Br J Cancer 2012;107(10):1783-90.

  78. Akbari MR, Trachtenberg J, Lee J, Tam S, Bristow R, Loblaw A, Narod SA, Nam RK. Association between germline HOXB13 G84E mutation and risk of prostate cancer. JNCI 2012;104: 1260-2.

  79. Akbari MR, Zhang S, Fan I, Royer R, Li S, Risch H, McLaughlin J, Rosen B, Sun P, Narod SA. Clinical impact of unclassified variants of the BRCA1 and BRCA2 genes. J Med Genet. 2011 Nov;48(11):783-6.

  80. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR; Australian National Endometrial Cancer Study Group; Epidemiology of Endometrial Cancer Consortium (E2C2), Goodman MT. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women. PLoS One. 2011 Feb 8;6(2):e16756.

  81. Akbari MR, Malekzadeh R, Lepage P, Roquis D, Sadjadi AR, Aghcheli K, Yazdanbod A, Shakeri R, Bashiri J, Sotoudeh M, Pourshams A, Ghadirian P, Narod SA. Mutations in Fanconi Anemia Genes and the Risk of Esophageal Cancer. Hum Genet 2010 may;129(5):573-82.

  82. Akbari MR, Tonin P, Foulkes WD, Ghadirian P, Tischkowitz M, Narod SA. RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res. 2010 Aug 19;12(4):404.

  83. Ghadirian P, Robidoux A, Zhang P, Royer R, Akbari MR, Zhang S, Fafard E, Costa M, Martin G, Potvin C, Patocskai E, Larouche N, Younan R, Nassif E, Giroux S, Narod SA, Rousseau F, Foulkes WD. The contribution of founder mutations to early-onset breast cancer in French-Canadian women. Clin Genet 2009 Nov; 76 (5):421-6.

  84. Akbari MR, Malekzadeh R, Shakeri R, Nasrollahzadeh D, Foumani M, Sun Y, Pourshams A, Sadjadi A, Jafari E, Sotoudeh M, Kamangar F, Boffetta P, Dawsey SM, Ghadirian P, Narod SA. Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res. 2009 Oct 15; 69 (20):7994-8000.

  85. Bentov Y, Brown TJ, Akbari MR, Royer R, Risch H, Rosen B, McLaughlin J, Sun P, Zhang S, Narod SA, Casper RF. Polymorphic variation of genes in the fibrinolytic system and the risk of ovarian cancer.. PLoS One. 2009 Jun 15; 4 (6):e5918.

  86. Ginsburg OM, Akbari MR, Aziz Z, Young R, Lynch H, Ghadirian P, Robidoux A, Londono J, Vasquez G, Gomes M, Costa MM, Dimitrakakis C, Gutierrez G, Pilarski R, Royer R, Narod SA. The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30. Fam Cancer. 2009; 8 (4):563-7.

  87. Setiawan VW, Doherty JA, Shu XO, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA, Hankinson SE, Henderson BE, Horn-Ross PL, Lacey JV Jr, Le Marchand L, Levine DA, Liang X, Lissowska J, Lurie G, McGrath M, Narod SA, Rebbeck TR, Ursin G, Weiss NS, Xiang YB, Yang HP, Zheng W, Olson SH. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18 (1):242-7.

  88. Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA. Germline RAP80 mutations and susceptibility to breast cancer. Breast Cancer Res Treat. 2009 Jan; 113 (2):377-81.

  89. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Islami F, Li S, Zandvakili I, Shakeri R, Sotoudeh M, Aghcheli K, Salahi R, Pourshams A, Semnani S, Boffetta P, Dawsey SM, Ghadirian P, Narod SA. Germline BRCA2 mutations and the risk of esophageal squamous cell carcinoma. Oncogene. 2008 Feb 21; 27 (9):1290-6.

  90. Rodriguez RC, Esperon AA, Ropero R, Rubio MC, Rodriguez R, Ortiz RM, Anta JJ, de los Rios M, Carnesolta D, del Olivera MC, Vansam SS, Royer R, Akbari MR, Donenberg T, Narod SA. Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Cuba. Fam Cancer. 2008; 7 (3) :275-9.

  91. Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res. 2007; 9 (6):R83.

  92. Malekzadeh R, Akbari MR. Prevalence of gluten-sensitive enteropathy and coeliac disease in Iran. Eur J Gastroenterol Hepatol. 2007 Sep;19(9):825-6

  93. Zogopoulous G, Rothenmund H, Eppel A, Ash C, Akbari MR, Hedley D, Narod SA, Gallinger S. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Hum Genet. 2007 Jun;121(5):635-7.

  94. Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, Sotoudeh M, Semnani S, Boffeta P, Dawsey SM, Ghadirian P, Narod SA. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. International Journal of Cancer. Int J Cancer. 2006 Sep 1;119(5):1047-51.

  95. Akbari MR, Mohammadkhani A, Fakheri H, Zahedi MJ, Shahbazkhani B, Nouraei M, Sotoudeh M, Shakeri R, Malekzadeh R. Adult population screening for celiac disease: Comparison of tissue-transglutaminase antibody and antiendomysial antibody tests. Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1181-6.

  96. Safaralizadeh R, Siavoshi F, Malekzadeh R, Akbari MR, Derakhshan MH, Sohrabi MR, Massarat S. Furazolidone Antimicrobial Effectiveness against Metronidazole Resistant Strains of H.Pylori. East Mediterr Health J. 2006 May-Jul;12(3-4):286-93.

  97. Imanzadeh F, Sayyari AA, Yaghoobi M, Akbari MR, Shafagh H, Farsar AR. Coeliac   disease in children with diarrhea is more frequent than previously suspected: A case-control study. Journal of Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2005 March; 40(3):309 -11

  98. Pourshams A, Malekzadeh R, Monavvari A, Akbari MR, Mohammadkhani A, Merat S, Seddighi N, Mohammadnejad M, Sotoudeh M, Madjlessi A. The prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors. Journal of Gastroenterology and Hepatology. J Gastroenterol Hepatol 2005 Feb;20(2):229 -33    

  99. Yaghoobi M, Rakhshani N, Sadr F, Bijarchi R, Joshaghani Y, Mohammadkhani A, Attari A, Akbari MR, Hormazdi M, Malekzadeh R. Hereditary risk factors for the development of gastric cancer in younger patients. BMC Gastroenterol. 2004 Oct 27;4(1):28.

  100. Rostami K, Malekzadeh R, Shahbazkhani B, Akbari MR, Catassi C. Coeliac Disease in Middle Eastern countries: a challenge for the evolutionary history of  this complex disorder? Dig Liver Dis. 2004 oct; 36(10):694-7.

  101. Nouraie M, Pourshams A, Kamangar F, Sotoudeh M, Derakhshan MH, Akbari MR,  Fakheri H, Zahedi MJ, Abnet CC, Taylor PR, Malekzadeh R, Dawsey SM. Ecologic Study   of Serum Selenium and Upper Gastrointestinal Cancers in Iran. World J Gastroenterol 2004; 10(17): 2547-9

  102. Shahbazkhani B, Mohammadnejad M, Malekzadeh R, Akbari MR,  Esfahani MM, Nasserimoghadam S, Sotoudeh M, Elahyfar A. Coeliac Disease is the Most Common Cause of Chronic Diarrhoea in Iran. Eur J Gastroenterol Hepatol. 2004 Jul;16(7):665-8.

  103. Shahbazkhani B, Faezi T, Akbari MR, Mohamadnejad M, Sotoudeh M, Rajab A ,       Tahaghoghi S, Malekzadeh R. Coeliac Disease in Iranian type I Diabetic Patients.       Digestive and Liver Disease. 2004 Mar;36(3):191-4

  104. Shahbazkhani B, Forootan M, Merat S, Akbari MR, Nasserimoghadam S, Vahedi H,      Malekzadeh R. Coeliac disease presenting with symptoms of irritable bowel syndrome. Aliment Pharmacol Ther. 2003 Jul;18(2):231-5

  105. Nahavandi A, Mani AR, Homayounfar H, Akbari MR, Dehpour AR. The role of the      interaction between endogenous opioids and nitric oxide in the pathophysiology of      ethanol-induced gastric damage in cholestatic rats. Fundam Clin Pharmacol 2001       Jun;15(3):181-7

  106. Mahmoudi S, Pourshams A, Akbari MR, Malekzadeh R. [The Prevalence of Irritable      Bowel Syndrome and Gastroesophageal Reflux Disease among new entrance of Tehran     University in 2001]. Gowaresh 2003; 8(4): 159- 62

  107. Pourshams A, Akbari MR. [The relative frequency of hepatitis B surface antigen among new entrants of tehran university in 2001]. Gowaresh 2003; 8(4): 126-131.

  108. Mohammadnejad M, Pourshams A, Sohrabpour A, Malekzadeh R, Akbari MR,   Mohammadkhani A, Rajabiani A, Zamani F, Faghihi A, Aliasgari A. [Healthy ranges of  Serum alanine aminotransferase levels in Iranian blood donors]. Gowaresh 2003; 8(4): 79 – 83